|
MTMR10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.59440000383427E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28020000553531E-08 |
| Normal-vs-Stage2 |
8.07870000000266E-05 |
| Normal-vs-Stage3 |
2.181700E-04 |
| Normal-vs-Stage4 |
1.79697999999062E-05 |
| Stage1-vs-Stage2 |
8.931400E-01 |
| Stage1-vs-Stage3 |
2.986000E-01 |
| Stage1-vs-Stage4 |
1.885800E-01 |
| Stage2-vs-Stage3 |
4.113800E-01 |
| Stage2-vs-Stage4 |
2.688800E-01 |
| Stage3-vs-Stage4 |
8.744800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68370000053208E-07 |
| Normal-vs-AfricanAmerican |
2.17039999999002E-05 |
| Normal-vs-Asian |
1.958879999997E-05 |
| Caucasian-vs-AfricanAmerican |
3.221200E-01 |
| Caucasian-vs-Asian |
8.064000E-02 |
| AfricanAmerican-vs-Asian |
2.455900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.77290000247643E-08 |
| Normal-vs-Female |
2.8555999997959E-07 |
| Male-vs-Female |
5.226000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.18939999996337E-06 |
| Normal-vs-Extreme_Weight |
1.16880000122777E-08 |
| Normal-vs-Obese |
2.35999999999015E-05 |
| Normal-vs-Extreme_Obese |
5.120100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.215800E-01 |
| Normal_Weight-vs-Obese |
4.226400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.671810E-01 |
| Extreme_Weight-vs-Obese |
4.316600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.118550E-01 |
| Obese-vs-Extreme_Obese |
4.202800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.06970000214002E-08 |
| Normal-vs-Age(41-60Yrs) |
2.160400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.51009998844631E-09 |
| Normal-vs-Age(81-100Yrs) |
3.9906000000034E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.160100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.309030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.800600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.369900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.804400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.353800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.25020000002674E-06 |
| Normal-VS-Type2 PRCC |
2.40919995064814E-09 |
| Normal-VS-KIRP CIMP |
2.47346587656239E-12 |
| Normal-VS-Unclassified PRCC |
1.639690E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.40069999999971E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.15940000220161E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
8.568800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.160730E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.976000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.08099999998712E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75429670790095E-11 |
| Normal-vs-N1 |
1.02949999969404E-07 |
| Normal-vs-N2 |
4.185000E-04 |
| N0-vs-N1 |
3.932600E-01 |
| N0-vs-N2 |
2.385000E-01 |
| N1-vs-N2 |
6.939200E-01 |
|
|
